Please assess the completion status of the following clinical trial:

Trial Title: Study of the Effect of Low Level Laser Light Therapy on Reducing the Appearance of Cellulite in the Thighs and Buttocks.

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: TRIPLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Areas for which cellulite appearance reduction is being sought are the bilateral thighs and buttocks~* Clinical cellulite gradation of Stage II or III on the Nurnberger-Muller scale for each treatment area~* PI or P2 on the American Society of Anesthesiologists (ASA) Physical Status Classification System~* Willing and able to abstain from partaking in any treatment other than the study procedure to promote cellulite appearance reduction/body contouring/weight loss during the study~* Willing and able to maintain regular diet and exercise regimen without effecting significant change in either direction during the study~* Willing and able to maintain regular medication schedule, as is medically feasible, during the study~Exclusion Criteria:~* Clinical cellulite gradation of Stage 0 or I on the Nurnberger Muller Scale (NMS) for either one or both thighs/buttocks~* P3 or P4 or P5 or P6 on the ASA Physical Status Classification System~* Weight fluctuation greater than 10 pounds in the prior month~* Previous attempt(s) to reduce cellulite in the study treatment areas over the past 6 months~* Prior surgical intervention to the treatment areas, for any reason~* Medical, physical or other contraindications for cellulite reduction/body contouring/weight loss~* Current use of medication(s) known to affect weight levels and/or cause bloating or swelling and for which abstinence during the study is not safe or medically prudent~* Any medical condition known to affect weight levels, cause bloating or swelling~* Diagnosis of, and/or taking medication for, irritable bowel syndrome~* Active infection, wound or other external trauma to the study treatment areas~* Dermatitis or significant scarring in the study treatment areas~* Medical, physical, or other contraindications for, or known sensitivity to, light therapy~* Diabetes dependent on insulin or oral hypoglycemic medications~* Known cardiovascular disease~* Cardiac surgeries~* History of deep venous thrombosis, arterial disease of the legs~* Pregnant, breast feeding, or planning pregnancy prior to study end~* Serious mental health illness or psychiatric hospitalization in past 2 years~* Developmental disability or cognitive impairment that would impact study participation~* Involved in litigation/receiving disability benefits related to the parameters of the study~* Participation in research in the past 30 days

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: 55 Years
- Healthy Volunteers: t

Study Arms:
- Erchonia Scanner device (GLS) (Type: EXPERIMENTAL): The Erchonia® GLS device is made up of six independent diodes, each emitting 17 milliwatts (mW), 532 nanometer (nm) of green laser light.
- Placebo device (Type: SHAM_COMPARATOR): Inactive Erchonia GLS device

Based on this trial design, predict the completion outcome and termination type (if applicable).

Answer: outcome: complete